Eton Pharmaceuticals, INC. (ETON) — 10-Q Filings

All 10-Q filings from Eton Pharmaceuticals, INC.. Browse 4 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (4)

Eton Pharma's Revenue Soars 114%, But Net Loss Widens to $6.08M — Nov 6, 2025 Risk: medium
Eton Pharmaceuticals, Inc. reported a significant increase in total net revenues for the nine months ended September 30, 2025, reaching $58,669 thousand, a subs
Eton Pharma Sees Revenue Surge in Q2 2025 on Product Sales — Aug 7, 2025 Risk: high
Eton Pharmaceuticals, Inc. reported a significant increase in total revenue for the three months ended June 30, 2025, reaching $10,000 compared to $0 in the pri
Eton Pharmaceuticals Q3 2024 10-Q Filed — Nov 12, 2024 Risk: medium
Eton Pharmaceuticals, Inc. filed its Q3 2024 10-Q report on November 12, 2024, for the period ending September 30, 2024. The company's financial statements show
Eton Pharmaceuticals, Inc. Files 10-Q for Q1 2024 — May 9, 2024 Risk: medium
Eton Pharmaceuticals, Inc. (ETON) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Eton Pharmaceuticals, Inc. filed a 10-Q report for the period end

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX